ARCHIVES

Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997

Congress Cuts $210 Million From NIH Budget For The Remainder of 2011

April 15, 2011

Breast Implants Lessen Ability Of Mammograms To Find Cancer

February 27, 2004

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007

PDX Shows 27% Response In T-Cell Lymphoma In Study

December 26, 2008

French Legion d’Honneur Bestowed On Hortobagyi.

March 1, 2002